Has Medtronic Neuromodulation had other FDA enforcement actions?

Yes. Argus HQ has recorded 36 total FDA actions tied to Medtronic Neuromodulation: 0 warning letters, 36 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2024-10-23; Argus observed and indexed it on 2026-07-16.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · device_recall · high

Medtronic Neuromodulation — Class II recall: Vanta Implantable Neurostimulator (INS), Model 977006

Name: FDA Recall Record — Medtronic Neuromodulation
Creator: Argus HQ
Published: 2024-10-23
License: https://argushq.ai/methodology

Event date: 2024-10-23 00:00:00Z
Observed: 2026-07-16 23:20:08Z
Source ID: Z-0132-2025
Payload hash: 0b03bdfc8dab449274707544…

Summary

Model 977006 Vanta INS batterty life has depleted faster than HCPs or patients expected leading to outpatient reprogramming or earlier than anticipated surgical replacements. Status: Ongoing.

Entities

Medtronic Neuromodulation

View source record ↗

Frequently asked questions

Has Medtronic Neuromodulation had other FDA enforcement actions?: Yes. Argus HQ has recorded 36 total FDA actions tied to Medtronic Neuromodulation: 0 warning letters, 36 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2024-10-23; Argus observed and indexed it on 2026-07-16.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2024). Medtronic Neuromodulation — Class II recall: Vanta Implantable Neurostimulator (INS), Model 977006. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0132-2025

MLA

"Medtronic Neuromodulation — Class II recall: Vanta Implantable Neurostimulator (INS), Model 977006." Argus HQ Research, Digital Empire Holdings LLC, 2024, argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0132-2025.

Chicago

Argus HQ Research. "Medtronic Neuromodulation — Class II recall: Vanta Implantable Neurostimulator (INS), Model 977006." Digital Empire Holdings LLC. Accessed July 23, 2026. https://argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0132-2025.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_medtronic_neuromodulation_z_0132_2025_2024,
  title = {Medtronic Neuromodulation — Class II recall: Vanta Implantable Neurostimulator (INS), Model 977006},
  author = {{Argus HQ Research}},
  year = {2024},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0132-2025},
  note = {Accessed: July 23, 2026}
}

Informational only. Not legal, financial, or medical advice.